Is this you?
Request access for Synergy Healthcare with your @synergyhealthcorp.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Intera lens
ICP 5Lift (cardio sample) 1.00Recruit soph 0
Quality Scorecard (1–100)
Overall62Recruit48Ops71Sponsor67Ther64
Performance (observed)
Historical trials
148
Completed
91
Terminated/Withdrawn
17
Completion rate
84%
Active now
36
Phase 2
53
Phase 3
83
Realized enrollment
282,414
First study year
2000
Years active
26
Match confidence
high
Enrollment velocity (inf)
10,862
Therapeutic
Areas
Cardiometabolic (cardiology/endocrinology/hepatology/renal, per ClinicalTrials.gov)
Breadth (conditions)
138
States
Florida
Recruitment (web observed)
Capability notes
5 active recruiting cardiometabolic trials (ClinicalTrials.gov)
Relationships
Sponsors
Pfizer; Eli Lilly and Company; AbbVie; Novo Nordisk A/S; Janssen Research & Development, LLC; Forest Laboratories
CROs
IQVIA Pty Ltd; Parexel; Premier Research; Teva Branded Pharmaceutical Products R&D, Inc.
Owner / parent
Unknown
Capacity & people
Investigators
—
Coordinators
—
Emails
sstickels@synergyhealthcorp.com
Tech & DCT
Builds tech
Unknown
Tech stack
Unknown
Recruiting visible
Y
Notes
Surfaced via ClinicalTrials.gov mining (not on curated lists). 5 active recruiting cardiometabolic trials across 1 location(s). Actively-recruiting independent site = warm Intera lead; website/leadership not yet verified.
Recommendation features (sample indication)
Ind fit 1.00Liftability 1.00Overall62
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.